---
name: Omniabio
slug: omniabio
site: cdmo
website_domain: omniabio.com
summary: OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages. Headquartered in Hamilton, Canada.
tagline: Cell and gene therapy CDMO with AI-enabled manufacturing from preclinical to commercial scale.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-08-16T07:00:51.105Z
services_count: 8
modalities_count: 2
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Omniabio

Cell and gene therapy CDMO with AI-enabled manufacturing from preclinical to commercial scale.

Listed on cdmo.directory.

## Summary

OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages. Headquartered in Hamilton, Canada.

## At a glance

- HQ country: CA

## Services

- Process Development
- CMC Analytical Development
- Cell-Line Development
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Cell Therapy Manufacturing
- Lentiviral Vector Manufacturing
- CMC Regulatory Submission Support

## Modalities

- Cell Therapy
- Gene Therapy

## Locations

- Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada

## Long description

## Overview

OmniaBio is a specialized contract development and manufacturing organization (CDMO) focused exclusively on cell and gene therapy (CGT). The company partners with biotech innovators to advance autologous and allogeneic cell therapies, lentiviral vector (LVV) platforms, and induced pluripotent stem cell (iPSC)-based programs from preclinical development through commercial-scale manufacturing.

## Core Services

- **Process Development & Optimization:** Expertise in developing and optimizing manufacturing platforms with enhanced robustness and reliable scale-up capabilities.
- **Analytical Development:** Comprehensive analytical development services for tailored and established assays.
- **GMP Manufacturing:** Resilient and scalable manufacturing with Grade B or Grade C GMP suite options compliant with U.S., Canadian, and European regulations.
- **Cell Banking:** Dedicated cell banking services supporting therapeutic programs.
- **Regulatory Guidance:** CMC program support and regulatory pathway navigation.
- **Supply Chain Security:** End-to-end supply chain oversight.

## Technology & Infrastructure

OmniaBio operates Canada's largest CGT manufacturing facility (120,000 sq ft) in Hamilton, Ontario. The facility integrates:

- **Hamilton Intelligent Facility:** AI and robotics integration for enhanced production rates and reduced manufacturing costs.
- **Closed-unit systems:** Automated, closed manufacturing platforms for consistency and risk mitigation.
- **Advanced cell platforms:** Purpose-built infrastructure for lentiviral vector, immune cell, and iPSC-based therapies.

## Differentiation

The company emphasizes phase-appropriate services, collaborative partnerships, and a focus on reducing risk and amplifying assurance. With over a decade of collective experience in immune cell-based therapy process development, OmniaBio positions itself as both a manufacturing partner and an innovation collaborator, supporting clients from early development through commercial supply.

## Related companies

- [Cell-Easy](/companies/cell-easy) (Process Development, CMC Analytical Development) — [Compare](/compare/cell-easy/omniabio)
- [Enable Biotech Ltd](/companies/enablebiotech) (Autologous Cell Therapy Manufacturing, Allogeneic Cell Therapy Manufacturing) — [Compare](/compare/enablebiotech/omniabio)
- [Cellipont Bioservices](/companies/cellipont-bioservices) (Process Development, CMC Analytical Development) — [Compare](/compare/cellipont-bioservices/omniabio)
- [Cell and Gene Therapy Catapult](/companies/ct) (Process Development, CMC Analytical Development) — [Compare](/compare/ct/omniabio)
- [Cell Therapies](/companies/celltherapies) (Process Development, CMC Analytical Development) — [Compare](/compare/celltherapies/omniabio)
- [Porton Advanced](/companies/porton-advanced) (Process Development, CMC Analytical Development) — [Compare](/compare/omniabio/porton-advanced)
- [Cellares](/companies/cellares) (Process Development, CMC Analytical Development) — [Compare](/compare/cellares/omniabio)
- [Pluri](/companies/pluri-biotech) (Process Development, CMC Analytical Development) — [Compare](/compare/omniabio/pluri-biotech)

_Profile last updated: 2026-08-16T07:00:51.105Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.